Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dana Atrakchi-Baranes"'
Autor:
Ari Robinson, Michal Schnaider Beeri, Sigal Liraz-Zaltsman, Avital Licht-Murava, Derek LeRoith, Dana Atrakchi-Baranes, Irit Lubitz, Pavel Katsel, Vahram Haroutunian
Publikováno v:
Journal of Molecular Neuroscience. 67:504-510
Disruption of brain insulin signaling may explain the higher Alzheimer's disease (AD) risk among type 2 diabetic (T2D) patients. There is evidence from in vitro and human postmortem studies that combination of insulin with hypoglycemic medications is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4929618824b985dccce6bd2b0315e328
https://doi.org/10.1007/s12031-019-1257-9
https://doi.org/10.1007/s12031-019-1257-9
Autor:
Anat Biegon, Barbara S. Slusher, Alcino J. Silva, Dana Atrakchi-Baranes, Kineret Rosenblatt, Efrat L. Kesner, Esther Shohami, Yael Friedman Levi, Sigal Liraz-Zaltsman
Publikováno v:
Journal of Neurotrauma. 35:1667-1680
Cognitive deficits, especially memory loss, are common and devastating neuropsychiatric sequelae of traumatic brain injury (TBI). The deficits may persist for years and may be accompanied by increased risk of developing early- onset dementia. Past at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8157e4b20d6d749daef2c6e8eb4e8b8
https://doi.org/10.1089/neu.2017.5561
https://doi.org/10.1089/neu.2017.5561
Autor:
Derek LeRoith, Dana Atrakchi-Baranes, Michal Schnaider-Beeri, Jaime Uribarri, Anna Maksin‐Matveev, Weijing Cai, Avshalom Leibowitz, James Schmeidler, Irit Lubitz, Jan Ricny, Itzik Cooper, Sigal Liraz-Zaltsman, Efrat Kravitz, Zdena Kristofikova, Chen Shemesh, Daniela Ripova
Publikováno v:
Aging Cell
Summary There is growing evidence of the involvement of advanced glycation end products (AGEs) in the pathogenesis of neurodegenerative processes including Alzheimer's disease (AD) and their function as a seed for the aggregation of Aβ, a hallmark f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80340ccd8b089a0499622ea34b6fc528
http://europepmc.org/articles/PMC4783343
http://europepmc.org/articles/PMC4783343
Autor:
Aviv Shish, Dana Atrakchi-Baranes, Sharone Naor, David Goez, Alicia Leikin-Frenkel, Shirin Elhaik Goldman, Michal Schnaider Beeri, Chen Shemesh, Yael Mardor, Rachel Twitto-Greenberg, Roni Lotan, Sigal Liraz Zaltsman, Shoval Tsach, Inbal Sharvit-Ginon, Itzik Cooper
Publikováno v:
Aging Cell
Type 2 diabetes (T2D) is associated with increased risk of Alzheimer's disease (AD). There is evidence for impaired blood–brain barrier (BBB) in both diseases, but its role in the interplay between them is not clear. Here, we investigated the effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b85a5ce0734e447a675bc5f9e1cb8f20
https://doi.org/10.1111/acel.12818
https://doi.org/10.1111/acel.12818